New guidelines recommend all patients with heart disease are tested for kidney disease
The first-ever European Society of Cardiology Guidelines on the management of cardiovascular disease and chronic kidney disease have been developed in collaboration with the European Renal Association. The new guidelines were published online in the European Heart Journal and presented at ESC Congress 2026 on Aug. 29.
The European Society of Cardiology and the European Renal Association have released new guidelines recommending that all patients with heart disease be tested for kidney disease. Chronic kidney disease (CKD) is defined as abnormalities in kidney structure or function lasting at least three months, and it increases the risk of various cardiovascular diseases.
The guidelines aim to improve screening, diagnosis, and treatment of both CKD and CVD by emphasizing the importance of regular screening, risk stratification, and early use of therapies like RAS inhibitors and SGLT2 inhibitors. The guidelines also recommend careful management of CVD medications in patients with reduced kidney function and promote effective communication and patient engagement between specialists.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
